Iindaba
-
Isifo sentliziyo sifuna iyeza elitsha – iVericiguat
Ukungaphumeleli kwentliziyo kunye neqhezu leejection elincitshisiweyo (HFrEF) luhlobo oluphambili lokungaphumeleli kwentliziyo, kwaye i-China HF Study ibonise ukuba i-42% yokusilela kwentliziyo e-China yi-HFrEF, nangona iiklasi ezininzi zonyango zonyango zikhoyo kwi-HFrEF kwaye zinciphise umngcipheko. kwe...Funda ngokugqithisileyo -
Ichiza ekujoliswe kulo unyango myelofibrosis: Ruxolitinib
I-Myelofibrosis (MF) ibizwa ngokuba yi-myelofibrosis. Kwakhona sisifo esinqabileyo kakhulu. Kwaye unobangela we-pathogenesis yayo awaziwa. Iimpawu zeklinikhi eziqhelekileyo ziseligazi elibomvu lolutsha kunye ne-granulocytic anemia yolutsha enenani eliphezulu lokukrazula kweeseli ezibomvu zegazi ...Funda ngokugqithisileyo -
Kufuneka wazi ubuncinane la manqaku e-3 malunga ne-rivaroxaban
Njenge-anticoagulant yomlomo omtsha, i-rivaroxaban isetyenziswe ngokubanzi ekukhuselweni kunye nokunyangwa kwesifo se-venous thromboembolic kunye nokukhusela i-stroke kwi-non-valvular atrial fibrillation. Ukuze usebenzise i-rivaroxaban ngokufanelekileyo, kufuneka wazi ubuncinane la manqaku e-3 ....Funda ngokugqithisileyo -
IChangzhou Pharmaceutical ifumene imvume yokuvelisa iLenalidomide Capsules
I-Changzhou Pharmaceutical Factory Ltd., i-subsidiary ye-Shanghai Pharmaceutical Holdings, ifumene iSatifikethi sokuBhalisa iDrug (iSitifiketi esinguNombolo 2021S01077, 2021S01078, 2021S01079) esikhutshwe nguRhulumente woLawulo lweDrugs kwiLenalidomide ....Funda ngokugqithisileyo -
Ziziphi izilumkiso zeepilisi ze-rivaroxaban?
I-Rivaroxaban, njenge-anticoagulant yomlomo omtsha, isetyenziswe ngokubanzi ekukhuseleni nasekunyangeni izifo ze-venous thromboembolic. Yintoni endiyidingayo ukuyiqwalasela xa ndithatha i-rivaroxaban? Ngokungafaniyo ne-warfarin, i-rivaroxaban ayifuni ukujongwa kwe-clotting indica ...Funda ngokugqithisileyo -
Ngo-2021 i-FDA eVunyiweyo yeChiza eNtsha 1Q-3Q
Utshintsho luqhubela phambili inkqubela. Xa kuziwa kubuchule obutsha kuphuhliso lwamachiza amatsha kunye neemveliso zonyango zebhayoloji, Iziko le-FDA loVavanyo lweZiyobisi kunye noPhando (CDER) lixhasa ishishini loxubo mayeza kuwo onke amanyathelo enkqubo. Ngokuqonda kwayo ...Funda ngokugqithisileyo -
Uphuhliso lwakutsha nje lweSugammadex Sodium ngexesha lokuvuka kwe-anesthesia
I-Sugammadex Sodium i-antagonist ye-novel ye-electroly non-depolarizing muscle relaxants (i-myorelaxants), eyaqala ukuxelwa ebantwini kwi-2005 kwaye sele isetyenziswe kwikliniki eYurophu, e-United States naseJapan. Xa kuthelekiswa namachiza emveli e-anticholinesterase...Funda ngokugqithisileyo -
Yeyiphi ithumba i-thalidomide esebenzayo ekunyangeni!
I-Thalidomide iyasebenza ekunyangeni la mathumba! 1. Apho amathumba aqinileyo anokuthi asetyenziswe i-thalidomide. 1.1. umhlaza wemiphunga. 1.2. Umhlaza wedlala lobudoda. 1.3. umhlaza wamaqhuqhuva. 1.4. hepatocellular carcinoma. 1.5. Umhlaza wesisu. ...Funda ngokugqithisileyo -
I-Tofacitinib Citrate
I-Tofacitinib citrate yiyeza elimiselweyo (igama lokurhweba i-Xeljanz) elaphuhliswa ekuqaleni nguPfizer kwiklasi ye-oral Janus kinase (JAK) inhibitors. Inokuthintela ngokukhethayo i-JAK kinase, ibhloke iindlela ze-JAK/STAT, kwaye ngaloo ndlela inqanda ukuhanjiswa komqondiso weseli kunye nokuchazwa kofuzo oluNxulumeneyo kunye nokuvula...Funda ngokugqithisileyo -
I-Apixaban kunye neRivaroxaban
Kwiminyaka yakutshanje, ukuthengiswa kwe-apixaban kukhule ngokukhawuleza, kwaye imarike yehlabathi sele idlule i-rivaroxaban. Ngenxa yokuba i-Eliquis (i-apixaban) inenzuzo ngaphezu kwe-warfarin ekukhuseleni i-stroke kunye nokuphuma kwegazi, kwaye i-Xarelto (i-Rivaroxaban) ibonise kuphela i-non-inferiority. Ukongeza, i-Apixaban ayifuni...Funda ngokugqithisileyo -
Umboniso we-API yaseGuangzhou ngo-2021
I-86th China International Pharmaceutical Raw Materials / Intermediates/Packaging/Equipment Fair (API China ngokufutshane) Umququzeleli: Reed Sinopharm Exhibition Co., Ltd. Ixesha lokubonisa: NgoMeyi 26-28, 2021 Indawo: I-China yokungenisa kunye nokuThumela ngaphandle kweFayile Complex (Guangzhou) Isikali somboniso: 60,000 square metres Ex...Funda ngokugqithisileyo -
Obeticholic acid
NgoJuni 29, i-Intercept Pharmaceuticals ibhengeze ukuba ifumene isicelo esipheleleyo sechiza esivela kwi-US FDA malunga ne-FXR agonist obeticholic acid (OCA) ye-fibrosis ebangelwa yi-non-alcoholic steatohepatitis (NASH) I-Response letter (CRL). I-FDA ithe kwi-CRL ukuba isekwe kwidatha...Funda ngokugqithisileyo